|
Variable
|
All patients
|
SA carriers
|
MRSA carriers
|
|---|
| |
(200 subjects)
|
(59 subjects)
|
(27 subjects)
|
|---|
|
Age
| | | |
|
18-29
|
54 (27%)
|
16 (27%)
|
7 (26%)
|
|
30-39
|
43 (21.5%)
|
15 (25.5%)
|
4 (15%)
|
|
40-49
|
55 (27.5%)
|
13 (22%)
|
9 (33%)
|
|
50-59
|
39 (19.5%)
|
13 (22%)
|
7 (26%)
|
|
60 and up
|
9 (4.5%)
|
2 (3.5)
|
0 (0%)
|
|
Sex
| | | |
|
Male
|
108 (54%)
|
26 (44%)
|
15 (55%)
|
|
Female
|
92 (46%)
|
33 (56%)
|
12 (45%)
|
|
Race
| | | |
|
White/Hispanic
|
38 (19%)
|
14 (24%)
|
4 (15%)
|
|
Black
|
159 (79.5%)
|
45 (76%)
|
23 (85%)
|
|
Asian, Pacific Islander
|
2 (1%)
|
0
|
0
|
|
American Indian Alaskan Native
|
0
|
0
|
0
|
|
Other
|
1 (0.5%)
|
0
|
0
|
|
Hispanic/Spanish origin
| | | |
|
Yes
|
3 (1.5%)
|
1 (2%)
|
0
|
|
No
|
195 (97.5%)
|
58 (98%)
|
27 (100%)
|
|
Unknown
|
2 (1%)
|
0
|
0
|
|
Primary complaint
| | | |
|
Respiratory
|
26 (13%)
|
6 (10.5%)
|
3 (11%)
|
|
GI
|
22 (11%)
|
7 (12%)
|
3 (11%)
|
|
Dermatology
|
5 (2.5%)
|
2 (3%)
|
1 (4%)
|
|
Localized pain/weakness
|
87 (43.5%)
|
20 (35.5%)
|
11 (41%)
|
|
UGI
|
7 (3.5%)
|
3 (4.5%)
|
1 (4%)
|
|
Injury
|
14 (7%)
|
4 (6%)
|
2 (7.5%)
|
|
Cardiovascular
|
19 (9.5%)
|
8 (13.5%)
|
3 (11%)
|
|
Other
|
18 (9%)
|
9 (15%)
|
3 (11%)
|
|
General pain/weakness
|
2 (1%)
|
0
|
0
|
|
Antibiotic prescribed
| | | |
|
Yes
|
39 (19%)
|
8 (14%)
|
5 (18.5%)
|
|
No
|
161 (79.5%)
|
49 (86%)
|
22 (71.5%)
|
|
Admission to hospital
| | | |
|
Yes
|
29 (14.5%)
|
13 (22%)
|
7 (26%)
|
|
No
|
171 (75.5%)
|
46 (78%)
|
20 (74%)
|
